about
Kuwanon V inhibits proliferation, promotes cell survival and increases neurogenesis of neural stem cellsCreating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders.Microfluidic bioreactor for dynamic regulation of early mesodermal commitment in human pluripotent stem cells.Microfluidic device generating stable concentration gradients for long term cell culture: application to Wnt3a regulation of β-catenin signaling.New insights into the mechanisms of embryonic stem cell self-renewal under hypoxia: a multifactorial analysis approach.A non-destructive culturing and cell sorting method for cardiomyocytes and neurons using a double alginate layer.Thinking inside the box. To cope with an increasing disease burden, drug discovery needs biologically relevant and predictive testing systemsHigh-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell researchThe establishment of mouse embryonic stem cell cultures on 96-well plates for high-throughput screening.Endothelial Cell Vascular Smooth Muscle Cell Co-Culture Assay For High Throughput Screening Assays For Discovery of Anti-Angiogenesis Agents and Other Therapeutic Molecules.Mechanobiology of human pluripotent stem cells.Bioreactor engineering of stem cell environmentsPluripotent stem cells: An in vitro model for nanotoxicity assessments.Assessment of potassium current in Royan B(1) stem cell derived cardiomyocytes by patch-clamp technique.Phytochemical analysis and toxicity investigation of stem bark of Scutia buxifolia Reissek.Stemazole promotes survival and preserves stemness in human embryonic stem cells.Stem cell bioprocessing for regenerative medicine
P2860
Q28543597-82301F01-2335-464E-B65F-281DBB9463E6Q30278015-51950D2D-7A45-413D-B61D-510B8B60028CQ30531102-9C3FCB1C-7FEC-4623-B984-DAC409B7C83DQ30584513-9B3D601E-57CC-4734-AE4C-7AD11458BFF1Q34305847-D122DA26-872B-48AE-916A-F6ECAEE07961Q34369544-7828BDA5-62BF-4A56-A562-51A736AE107EQ36921931-345DA584-4DB5-42DE-BB60-097758F31650Q37461728-123E7B30-E7AE-4C33-B69F-BDB2C4A51904Q37462170-9B4FCB79-912F-4E5E-800C-B0F536D2D5D9Q37833506-71B73892-169F-498B-848F-B8F258F8CC29Q38087639-E31B5052-3CF0-47F3-B030-E5AFED91E854Q38093335-46F63278-6684-4573-98F2-D4086C885D8AQ38848644-B8065A56-CBCA-4168-A28A-5611DFAAF420Q42733030-435FDD74-B6C2-4E86-A8E5-F38E68173D36Q46748039-7CDB75BA-5AF3-46EC-9D37-4A865B0FAC98Q49985191-BB450CB2-EEE1-4CD5-863A-7E871B700FCCQ59062755-CCA37A1C-F34C-47BC-91BE-6F744D7C9B05
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Pharmaceutical applications of embryonic stem cells.
@ast
Pharmaceutical applications of embryonic stem cells.
@en
type
label
Pharmaceutical applications of embryonic stem cells.
@ast
Pharmaceutical applications of embryonic stem cells.
@en
prefLabel
Pharmaceutical applications of embryonic stem cells.
@ast
Pharmaceutical applications of embryonic stem cells.
@en
P1476
Pharmaceutical applications of embryonic stem cells.
@en
P2093
Colin W Pouton
John M Haynes
P304
P356
10.1016/J.ADDR.2005.08.003
P407
P577
2005-11-09T00:00:00Z